Hypoxia and hypoxia inducible factors in tumor metabolism

W Zeng, P Liu, W Pan, SR Singh, Y Wei - Cancer letters, 2015 - Elsevier
Because of the abnormal vasculature, most growing solid tumors contain regions that
experience either acute or chronic hypoxia. However, tumor cells can maintain a high …

Interfering with tumor hypoxia for radiotherapy optimization

I Telarovic, RH Wenger, M Pruschy - Journal of Experimental & Clinical …, 2021 - Springer
Hypoxia in solid tumors is an important predictor of treatment resistance and poor clinical
outcome. The significance of hypoxia in the development of resistance to radiotherapy has …

Cell‐specific blood–brain barrier regulation in health and disease: a focus on hypoxia

S Engelhardt, S Patkar… - British journal of …, 2014 - Wiley Online Library
The blood–brain barrier (BBB) is a complex vascular structure consisting of microvascular
endothelial cells that line the vessel wall, astrocyte end‐feet, pericytes, as well as the basal …

Two-dimensional transition metal dichalcogenide nanomaterials for combination cancer therapy

L Gong, L Yan, R Zhou, J Xie, W Wu… - Journal of Materials …, 2017 - pubs.rsc.org
As demonstrated by preclinical and clinical studies, it is often difficult to eradicate tumors,
particularly those that are deep-located, with photothermal therapy (PTT) alone because of …

[PDF][PDF] Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC

Y Fang, Y Zhan, Y Xie, S Du, Y Chen, Z Zeng… - …, 2022 - Wiley Online Library
Abstract Background and Aims Poor response to ionizing radiation (IR) due to resistance
remains a clinical challenge. Altered metabolism represents a defining characteristic of …

Emerging plasmonic nanoparticles and their assemblies for cancer radiotherapy

Y Wu, K Zhu, X Zhang, W Du, J Song, H Yang - Advanced Drug Delivery …, 2023 - Elsevier
Plasmonic nanoparticles and their assemblies have been widely used in biosensing, optical
imaging, and biomedicine over the past few decades. Especially in the field of radiotherapy …

TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator

YP Tsai, HF Chen, SY Chen, WC Cheng, HW Wang… - Genome biology, 2014 - Springer
Background Hypoxia induces the epithelial-mesenchymal transition, EMT, to promote
cancer metastasis. In addition to transcriptional regulation mediated by hypoxia-inducible …

Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis

X Tang, G Li, L Shi, F Su, M Qian, Z Liu, Y Meng… - Nature …, 2021 - nature.com
Dietary interventions such as intermittent fasting (IF) have emerged as an attractive strategy
for cancer therapies; therefore, understanding the underlying molecular mechanisms is …

Cancer biomarker discovery: current status and future perspectives

K Mäbert, M Cojoc, C Peitzsch, I Kurth… - … journal of radiation …, 2014 - Taylor & Francis
Purpose: Cancer is a multigene disease which arises as a result of mutational and
epigenetic changes coupled with activation of complex signaling networks. The use of …

Role of hypoxia-mediated autophagy in tumor cell death and survival

RF Zaarour, B Azakir, EY Hajam, H Nawafleh… - Cancers, 2021 - mdpi.com
Simple Summary Autophagy is a self-eating mechanism that is involved in the degradation
of organelles and cellular materials. It is initiated by intracellular and extracellular stress …